Globus Medical, Inc. Class A Common Stock (GMED)
R&D Expense Growth
-0.52%
Quarterly · Period ending:
GMED R&D Expense Growth
Latest reported-0.52%period ending
Latest reported-0.52%period ending
GMED Quarterly R&D Growth (QoQ) (0.00% → -0.52%)
Latest values, visible window
High-resolution chart · PNG
GMED r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -0.5177% | |
| -50.6068% | |
| 94.1761% | |
| -4.7229% | |
| 20.8457% | |
| -1.0357% | |
| -5.5738% | |
| -6.1489% | |
| -34.1727% | |
| 9.5996% | |
| 78.1581% | |
| 37.3917% | |
| 1.257% | |
| 8.074% | |
| 4.3099% | |
| 7.5079% | |
| -0.0976% | |
| -65.8735% | |
| 221.8444% | |
| 1.9682% | |
| 4.1745% | |
| -2.0799% | |
| 5.6862% | |
| -63.4495% | |
| 156.168% | |
| -0.6066% | |
| 6.81% | |
| -7.8623% | |
| 9.9274% | |
| 4.114% | |
| -11.3931% | |
| 14.8192% | |
| 6.5726% | |
| 11.1802% | |
| 4.8315% | |
| 1.6242% | |
| 0.4407% | |
| -21.8207% | |
| 32.9079% | |
| -3.1055% | |
| 5.6231% | |
| 1.9723% | |
| 6.3351% | |
| 1.861% | |
| 4.9099% | |
| 2.9986% | |
| 3.1672% | |
| 5.8747% | |
| 3.3723% | |
| 15.9707% | |
| -2.2838% | |
| -6.6648% | |
| 2.7749% | |
| -5.2712% | |
| 2.9336% | |
| 1.1816% | |
| 3.0285% | |
| 16.6811% | |
| -2.4172% | |
| 3.1561% | |
| -5.0497% | |
| 0% |